Annual accounts
Full accounts
30/09/2027Filing deadline
Made up to 31/12/2025Due 30/09/2027
- Next accounts made up to
- 31/12/2026
- Last accounts made up to
- 31/12/2025
ASPIRE PHARMA LIMITED
ActiveRegistry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- 102 High Street, Godalming, Surrey GU7 1DS
- Classification (SIC)
- Wholesale of pharmaceutical goods (46.46 - SIC 2007)
- Accounts type
- Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 29/08/2026View PDF (48 pages)
Full accounts made up to 2025-12-31
- 11/09/2025View PDF (3 pages)
Confirmation statement made on 2025-08-22 with no updates
- 04/07/2025View PDF (44 pages)
Full accounts made up to 2024-12-31
- 22/08/2024View PDF (3 pages)
Confirmation statement made on 2024-08-22 with no updates
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
On schedule
Confirmation statement
Confirms the registry record is up to date
05/09/2027Filing deadline
Last statement 22/08/2026Due 05/09/2027
- Next statement date
- 22/08/2027
- Last statement dated
- 22/08/2026
Financial performance
The latest figures ASPIRE PHARMA LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
£87.62M2025
33.17%vs 20242024: £65.80M
Total Assets
£124.50M2025
28.98%vs 20242024: £96.53M
Cash in Bank
£7.03M2025
-17.32%vs 20242024: £8.51M
Total Liabilities
£36.00M2025
17.80%vs 20242024: £30.56M
Employees
12025
0vs 20242024: 1
Of the 4 measures with an earlier filing to compare against, 3 rose and 1 fell. Total assets moved furthest, up 28.98% on 2024. See the full financial analysis for ASPIRE PHARMA LIMITED.
The full financial record
Four ways through ASPIRE PHARMA LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · +34.4% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2025.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 5 yearsEvery figure by yearAll 5 measures Okredo tracks across 5 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 1 | 0 |
| 2024 | 1 | -78 |
| 2023 | 79 | +8 |
| 2022 | 71 | +8 |
| 2021 | 63 | – |
Reported employee count decreased from 63 in 2021 to 1 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
16Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 22/06/2009–03/09/2021 | 25 | |
| Director | 24/02/2009–24/02/2009 | 28543 | |
| Director | 15/06/2020–Present | 15 | |
| Director | 12/11/2013–31/05/2020 | 8 | |
| Director | 15/06/2020–03/09/2021 | 12 | |
| Director | 22/06/2009–21/11/2013 | 3 | |
| Director | 15/11/2010–09/12/2014 | 0 | |
| Director | 11/01/2010–11/10/2010 | 1 | |
| Secretary | 15/06/2020–Present | 0 | |
| Secretary | 12/11/2013–31/05/2020 | 0 | |
| Director | 09/12/2014–03/09/2021 | 13 | |
| Director | 14/05/2009–28/02/2011 | 2 | |
| Director | 24/02/2009–14/05/2009 | 0 | |
| Director | 09/12/2014–03/09/2021 | 8 | |
| Director | 15/06/2020–Present | 13 | |
| Director | 28/04/2023–Present | 11 |
Persons with significant control
3Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 06/04/2016–04/09/2019 | 0 | |
| 04/09/2019–19/09/2019 | 1 | |
| 19/09/2019–Present | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 103
- Since 24/02/2009
- Last 12 months
- 1
- -1 vs the year before
- Most recent filing
- 29/08/2026
- 1 month ago
What changed in the last year
- Accounts filedLatest 29/08/2026
Filing timeline
- 29/08/2026View PDF (48 pages)
Full accounts made up to 2025-12-31
- 11/09/2025View PDF (3 pages)
Confirmation statement made on 2025-08-22 with no updates
- 04/07/2025View PDF (44 pages)
Full accounts made up to 2024-12-31
- 22/08/2024View PDF (3 pages)
Confirmation statement made on 2024-08-22 with no updates
- 25/07/2024View PDF (37 pages)
Full accounts made up to 2023-12-31
- 10/01/2024View PDF (2 pages)
Resolutions
- 10/01/2024View PDF (7 pages)
Memorandum and Articles of Association
- 22/08/2023View PDF (3 pages)
Confirmation statement made on 2023-08-22 with no updates
- 12/07/2023View PDF (37 pages)
Full accounts made up to 2022-12-31
- 02/05/2023View PDF (2 pages)
Appointment of Mr Richard Michael Condon as a director on 2023-04-28
- 02/05/2023View PDF (2 pages)
Director's details changed for Mr Jonathan Charles May on 2023-04-28
- 02/05/2023View PDF (2 pages)
Director's details changed for Mr Gary David Buckley on 2023-04-28
Showing 12 of 103 filings
See when the next accounts and confirmation statement are due
Similar companies
326 UK companies are similar to ASPIRE PHARMA LIMITED, sharing the same company status (Active), the same industry sector and activity group (Wholesale of pharmaceutical goods) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
DLH PETROLI (GB) LIMITED
Active120 New Cavendish Street, London W1W 6XX
- Activity
- Agents involved in the sale of fuels ores metals and industrial chemicals
- Company no.
- 12525549
- Incorporated
- 19/03/2020
- Employees
- 2
GETECH LIMITED
ActiveSolutions Centre, Knightsdale Road, Ipswich, Suffolk IP1 4JQ
- Activity
- Wholesale of computers computer peripheral equipment and software
- Company no.
- 02436537
- Incorporated
- 26/10/1989
- Employees
- 1
TILE CONSULT NORTHWEST LIMITED
ActiveOffice 101 280 Mare Street, London E8 1HE
- Activity
- Agents involved in the sale of timber and building materials
- Company no.
- 10186314
- Incorporated
- 18/05/2016
- Employees
- 1
L & M IMAGING SYSTEMS LIMITED
ActiveBarclays Bank Chambers, 12 Market Street, Hebden Bridge, West Yorkshire HX7 6AD
- Activity
- Non-specialised wholesale trade
- Company no.
- 02230297
- Incorporated
- 15/03/1988
- Employees
- 2
A & N FEED LTD
ActiveRivenhall, Burway Road, Church Stretton, Shropshire SY6 6DP
- Activity
- Wholesale of grain unmanufactured tobacco seeds and animal feeds
- Company no.
- 06532745
- Incorporated
- 12/03/2008
- Employees
- 2
About ASPIRE PHARMA LIMITED
A short description of the company, written from its Companies House record.
ASPIRE PHARMA LIMITED is a private limited company registered in the United Kingdom, based in 102 High Street, Godalming, Surrey GU7 1DS. Companies House classifies its business as Wholesale of pharmaceutical goods. It has been on the register for 17 years 7 months.
The register currently records it as active. Its 2025 accounts report net assets of £87.62M and 1 employee.
ASPIRE PHARMA LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
Companies House records ASPIRE PHARMA LIMITED under one registered business activity: Wholesale of pharmaceutical goods (46.46 - SIC 2007).
ASPIRE PHARMA LIMITED is recorded as active on the Companies House register, and has been on it since 24/02/2009.
The most recent accounts Okredo holds cover 2025 and report net assets of £87.62M, total assets of £124.50M, cash in bank of £7.03M and total liabilities of £36.00M.
The most recent document on the record is dated 29/08/2026: Full accounts made up to 2025-12-31, 1 month ago.
On the current registry record, accounts are due by 30/09/2027 and the next confirmation statement is due by 05/09/2027.
Companies House lists 16 officers (4 currently in post) and 3 people with significant control (1 current).